Legislation roundup: Strategic investment, delisting and pharma
Aug 2, 2018
Requirements for strategic investment in A-share companies are lowered, major violations of the law are specified in the delisting system and MAHs may entrust the sale of pharmaceuticals.
This premium content is reserved for
China Law & Practice Subscribers.
- Unlimited access to Chinalawandpractice.com site and digital newsletters
- 3 free articles* across the ALM subscription network every 30 days
- Exclusive discounts on ALM events and publications
Continue reading by getting
started with a subscription.